Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
6
NCT05462587
A Study to Evaluate Efficacy and Safety of AVTX-803 in Patients with Leukocyte Adhesion Deficiency Type II
Phase: Phase 3
Role: Lead Sponsor
Start: Jul 28, 2022
Completion: Nov 30, 2024
NCT05754450
An Extension Study Assessing the Safety and Efficacy of AVTX-803 in Subjects with Leukocyte Adhesion Deficiency Type II
Start: Apr 10, 2023
Completion: Dec 31, 2024